Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Use of Fertility Drugs and Risk of Uterine Cancer: Results From a Large Danish Population-based Cohort Study
American Journal of Epidemiology, 11/04/09
Jensen A et al. – Ever use of any fertility drug was not associated with uterine cancer risk. However, ever use of gonadotropins (follicle–stimulating hormone and human menopausal gonadotropin) increased uterine cancer risk; the risk was primarily observed after 10 years of follow–up. Furthermore, uterine cancer risk increased with number of cycles of use for clomiphene and human chorionic gonadotropin but not for other gonadotropins. Use of gonadotropin–releasing hormone analogs was not associated with risk. Gonadotropins, and possibly clomiphene and human chorionic gonadotropin, may increase the risk of uterine cancer, with higher doses and longer follow–up leading to greater risk.
Related Articles
Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer
American Journal of Epidemiology, 11/09/09
Relevance Score: 79%
Effectiveness of cervical cancer screening at different ages
Women's Health, 10/30/09
Relevance Score: 77%
Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer
Cochrane Reviews, 10/09/09
Relevance Score: 77%
Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
The Journal of Nutrition, 10/08/09
Relevance Score: 77%
Does screening history explain the ethnic differences in stage at diagnosis of cervical cancer in New Zealand?
International Journal of Epidemiology, 10/08/09
Relevance Score: 77%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies
British Journal of Clinical Pharmacology, 11/24/09
Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain
Current Anaesthesia and Critical Care, 11/24/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/24/09
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
DPP-4 Inhibitors in Clinical Practice
Postgraduate Medicine, 11/24/09
Sponsor
Article Search
Sponsor


See All


